Clinical Trial Update: PENG Block Optimization: Volume and Dexamethasone Effects [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating how injection volume and dexamethasone affect PENG block outcomes in hip conditions; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hip Arthritis
• Hip Arthropathy
• Hip Osteoarthritis

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: Poznan University of Medical Sciences | Conditions: Hip Arthropathy, Hip Osteoarthritis | Phase 4 | Status: COMPLETED